Craniosynostosis in Inactivating PTH/PTHrP Signaling Disorder 2: A Non-Classical Feature to Consider
1Pediatric Endocrinology. Pediatrics. Hospital Universitario Central de Asturias, Oviedo, Spain. 2University of Oviedo, Oviedo, Spain. 3Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. 4APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, filière OSCAR and Plateforme d´éxpertise Maladies Rares Paris-Sud, Le Kremlin Bicètre, France. 5APHP, Department of Endocrinology and Diabetology, Bicêtre Paris Sud hospital, Le Kremlin Bicètre, France. 6APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, filière OSCAR and Plateforme déxpertise Maladies Rares Paris-Sud, Le Kremlin Bicètre, France. 7INSERM U1169, Hôpital Bicêtre, Le Kremlin Bicètre, France. 8Fondazione IRCCS Ca´Granda Ospedale Maggiore Policlinico, Endocrinology and Diabetology Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. 9Molecular (Epi)Genetics Laboratory, bioAraba National Health Institute, OSI Araba University Hospital, Vitoria-Gasteiz, Spain
hrp0092fc6.6